Shares of Humana Inc. (NYSE:HUM – Get Free Report) gapped up before the market opened on Friday after TD Cowen upgraded the stock from a hold rating to a buy rating. The stock had previously closed at $380.00, but opened at $392.54. TD Cowen now has a $485.00 price target on the stock, up from their previous price target of $430.00. Humana shares last traded at $397.0840, with a volume of 216,814 shares.
A number of other brokerages have also weighed in on HUM. Barclays raised their price target on shares of Humana from $582.00 to $587.00 and gave the company an “overweight” rating in a research note on Monday, November 9th. UBS Group upped their price target on Humana from $405.00 to $495.00 and gave the company a “neutral” rating in a research report on Monday, October 12th. Evercore raised shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a research report on Wednesday, July 29th. Citigroup began coverage on Humana in a research report on Friday, October 9th. They issued a “buy” rating for the company. Finally, Deutsche Bank began coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating for the company. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $491.74.
Get Our Latest Stock Report on Humana
Insider Activity at Humana
In other Humana news, insider Joseph Ventura sold 5,495 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $433.85, for a total value of $2,384,005.75. Following the sale, the insider directly owned 21,910 shares of the company’s stock, valued at approximately $9,505,653.50. This represents a 20.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.20% of the company’s stock.
Key Headlines Impacting Humana
Investors following HUM have been watching these headlines:
- Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $9.50 from $9.05 and its Q1 2028 estimate to $11.72 from $11.53, while maintaining a “Strong Buy” rating. Morgan Stanley also raised its price target to $475 from $370, though it kept an “Equal Weight” rating. MarketBeat Humana coverage
- Neutral Sentiment: Humana plans to bring some employees back to its downtown Louisville offices starting in 2027; the change is not expected to be a major near-term stock driver. Article on Humana office plans
- Negative Sentiment: Zacks cut its Q3 2028 EPS forecast to $6.38 from $6.58, partially offsetting its upward revisions for other periods. Separately, an investor law firm announced an investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risks. Investigation notice
Hedge Funds Weigh In On Humana
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Johnson Financial Group Inc. acquired a new stake in Humana during the 2nd quarter worth $26,000. Trust Co. of Vermont purchased a new position in Humana in the 2nd quarter valued at about $28,000. Bogart Wealth LLC grew its holdings in Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the period. MidFirst Bank acquired a new stake in shares of Humana during the 2nd quarter worth $35,000. Finally, Highland Investment Advisors LLC acquired a new position in shares of Humana during the 2nd quarter valued at $43,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana Trading Up 4.2%
The business’s 50-day moving average price is $409.87 and its 200 day moving average price is $321.41. The firm has a market capitalization of $47.57 billion, a price-to-earnings ratio of 38.73, a PEG ratio of 1.84 and a beta of 0.65. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.65.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.30. Humana had a return on equity of 8.50% and a net margin of 0.81%. The business had revenue of $41.16 billion for the quarter, compared to analysts’ expectations of $40.87 billion. During the same period in the prior year, the firm earned $3.24 EPS. The business’s quarterly revenue was up 26.1% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.500- EPS. On average, equities analysts forecast that Humana Inc. will post 9.66 earnings per share for the current fiscal year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 24th will be issued a $0.8850 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s dividend payout ratio is 34.44%.
About Humana
Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.
Further Reading
- Five stocks we like better than Humana
- Palo Alto Networks’ Q1 Beat Gives Its Stock Rally Another Reason to Run
- Airfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter Test
- Hard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring
- Tesla and SpaceX May Form a $3.4 Trillion Giant, But Who Really Benefits?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
